BIIB vs. CAH
Compare and contrast key facts about Biogen Inc. (BIIB) and Cardinal Health, Inc. (CAH).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: BIIB or CAH.
Correlation
The correlation between BIIB and CAH is 0.41, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
BIIB vs. CAH - Performance Comparison
Loading data...
Key characteristics
BIIB:
-1.61
CAH:
2.69
BIIB:
-2.40
CAH:
3.48
BIIB:
0.73
CAH:
1.48
BIIB:
-0.59
CAH:
3.37
BIIB:
-1.44
CAH:
16.18
BIIB:
30.91%
CAH:
3.78%
BIIB:
28.39%
CAH:
22.19%
BIIB:
-90.00%
CAH:
-61.58%
BIIB:
-73.61%
CAH:
0.00%
Fundamentals
BIIB:
$18.40B
CAH:
$36.82B
BIIB:
$10.12
CAH:
$6.40
BIIB:
12.41
CAH:
24.10
BIIB:
6.24
CAH:
0.80
BIIB:
1.87
CAH:
0.17
BIIB:
1.07
CAH:
16.07
BIIB:
$9.70B
CAH:
$222.29B
BIIB:
$7.15B
CAH:
$7.78B
BIIB:
$2.15B
CAH:
$2.81B
Returns By Period
In the year-to-date period, BIIB achieves a -17.87% return, which is significantly lower than CAH's 31.47% return. Over the past 10 years, BIIB has underperformed CAH with an annualized return of -10.99%, while CAH has yielded a comparatively higher 8.90% annualized return.
BIIB
-17.87%
5.88%
-21.50%
-45.53%
-16.90%
-10.99%
CAH
31.47%
14.51%
30.90%
58.46%
27.84%
8.90%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
BIIB vs. CAH — Risk-Adjusted Performance Rank
BIIB
CAH
BIIB vs. CAH - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Biogen Inc. (BIIB) and Cardinal Health, Inc. (CAH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
BIIB vs. CAH - Dividend Comparison
BIIB has not paid dividends to shareholders, while CAH's dividend yield for the trailing twelve months is around 1.31%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BIIB Biogen Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
CAH Cardinal Health, Inc. | 1.31% | 1.28% | 1.98% | 2.57% | 3.80% | 3.62% | 3.79% | 4.24% | 2.99% | 2.41% | 1.68% | 1.65% |
Drawdowns
BIIB vs. CAH - Drawdown Comparison
The maximum BIIB drawdown since its inception was -90.00%, which is greater than CAH's maximum drawdown of -61.58%. Use the drawdown chart below to compare losses from any high point for BIIB and CAH. For additional features, visit the drawdowns tool.
Loading data...
Volatility
BIIB vs. CAH - Volatility Comparison
Biogen Inc. (BIIB) has a higher volatility of 9.33% compared to Cardinal Health, Inc. (CAH) at 7.45%. This indicates that BIIB's price experiences larger fluctuations and is considered to be riskier than CAH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
BIIB vs. CAH - Financials Comparison
This section allows you to compare key financial metrics between Biogen Inc. and Cardinal Health, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
BIIB vs. CAH - Profitability Comparison
BIIB - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Biogen Inc. reported a gross profit of 1.80B and revenue of 2.43B. Therefore, the gross margin over that period was 74.1%.
CAH - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Cardinal Health, Inc. reported a gross profit of 2.12B and revenue of 54.88B. Therefore, the gross margin over that period was 3.9%.
BIIB - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Biogen Inc. reported an operating income of 625.20M and revenue of 2.43B, resulting in an operating margin of 25.7%.
CAH - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Cardinal Health, Inc. reported an operating income of 730.00M and revenue of 54.88B, resulting in an operating margin of 1.3%.
BIIB - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Biogen Inc. reported a net income of 240.50M and revenue of 2.43B, resulting in a net margin of 9.9%.
CAH - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Cardinal Health, Inc. reported a net income of 506.00M and revenue of 54.88B, resulting in a net margin of 0.9%.